Celularity, Inc. (CELU) vs NanoViricides, Inc. (NNVC)
Celularity, Inc. and NanoViricides, Inc. are both Biotechnology companies. Celularity, Inc. and NanoViricides, Inc. are of similar size ($38.2M and $38.0M). NanoViricides, Inc. has the higher net margin (0.00% vs −345.8%) and the higher return on invested capital (−86.0% vs −1,070.9%). Across the 13 metrics below, NanoViricides, Inc. leads on 8 and Celularity, Inc. on 5.
Valuation
Profitability
| Metric | CELU | NNVC | Biotechnology median |
|---|---|---|---|
| Gross margin | 24.39% | 0.00% | 65.16% |
| Operating margin | (230.92%) | 0.00% | 0.00% |
| Net margin | (345.76%) | 0.00% | 0.00% |
| Free cash flow margin | (49.92%) | 0.00% | 0.00% |
| Return on equity | 628.23% | (89.97%) | (57.72%) |
| Return on assets | (76.50%) | (79.91%) | (49.22%) |
| Return on invested capital | (1,070.92%) | (86.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack